B
ANAB icon

Braidwell’s AnaptysBio ANAB Stock Holding History

Braidwell’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,049,823
Closed -$18.9M – 75
2023
Q3 		$18.9M Sell
1,049,823
-104,600
-9% -$2M 0.6% 56
2023
Q2 		$23.5M Buy
1,154,423
+181,350
+19% +$3.68M 0.77% 45
2023
Q1 		$21.2M Buy
973,073
+246,951
+34% +$6M 0.7% 49
2022
Q4 		$22.5M Buy
+726,122
New +$20.5M 0.75% 48

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Braidwell's ANAB Position: Q4 2023 in Review

Braidwell sold out of AnaptysBio (ANAB) in Q4 2023, closing a stake of 1,049,823 shares — an estimated $18.9M sold.

Braidwell first reported a position in ANAB in Q4 2022 and held it in 4 quarters. The position peaked at $23.5M in Q2 2023. 119 funds tracked by Wall St. Rank hold ANAB as of Q4 2023.

  • Braidwell reported no remaining AnaptysBio position as of Q4 2023 after selling out during the quarter.
  • Braidwell sold 1,049,823 AnaptysBio shares in Q4 2023, an estimated $18.9M.
  • Braidwell first reported a position in AnaptysBio in Q4 2022 and held it in 4 quarters.
  • Braidwell's AnaptysBio position peaked at $23.5M in Q2 2023.
  • 119 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2023.

Based on Braidwell's 13F filing for Q4 2023, filed 14 Feb 2024.